CFO moves: week of July 20–26, 2026

The week in numbers

SEC filings captured 18 CFO moves in the week of July 20–2026-07-26, bringing the July month-to-date total to 72. Of the 18 events, 7 were appointments, 6 were transitions, 3 were interim designations, and 2 were departures. Interim assignments made up 16.7% of the week's activity. Of the 16 seats that were filled, 7 came from internal promotions and 7 from external hires; for the remaining 2, the internal-versus-external distinction was not established. For 12 of the 18 individuals stepping into CFO roles, it could not be established whether this was a first-time CFO assignment; 4 had held the role before, and 0 were confirmed first-timers. No departure tenure data were available, so no median figure is reported.

Sectors and selected moves

Biological Products led all sectors with 3 moves, followed by Pharmaceutical Preparations with 2. The remaining sectors each recorded 1 move, spanning industries from Retail-Grocery Stores to Pumps and Pumping Equipment.

Among the named moves, Albertsons Companies recorded the departure of Sharon McCollam, with no effective date stated and no successor identified in the filing. GE HealthCare Technologies named George Newcomb as interim CFO, replacing James K. (Jay) Saccaro effective 2026-08-14. Aterian disclosed the departure of Joshua Feldman, effective 2026-09-04, with no incoming CFO named. Popular announced a transition from Jorge J. García to Lidio V. Soriano, effective 2026-09-01. The Gorman-Rupp Company recorded the latest-dated transition of the week, with Ronald F. Stoops set to replace James C. Kerr on 2026-10-01. Other transitions included Collective Acquisition Corp., Neuronetics, ImageneBio, and SharonAI Holdings. Appointments were filed for Armata Pharmaceuticals, Kalaris Therapeutics, Polomar Health Services, CrossAmerica Partners, Upland Software, Fermi Inc., and Sidus Space. Keros Therapeutics and MediaCo Holding also recorded interim designations.